| Health / Medical Topics |
Demcizumab
A humanized monoclonal antibody directed against the N-terminal epitope of Notch ligand DLL4 (delta-like 4) with potential antineoplastic activity. Demcizumab binds to the membrane-binding portion of DLL4 and prevents its interaction with Notch-1 and Notch-4 receptors, thereby inhibiting Notch-mediated signaling and gene transcription, which may impede tumor angiogenesis. Activation of Notch receptors by DLL4 stimulates proteolytic cleavage of the Notch intracellular domain (NICD); after cleavage, NICD is translocated into the nucleus and mediates the transcriptional regulation of a variety of genes involved in vascular development. The expression of DLL4 is highly restricted to the vascular endothelium. (NCI Thesaurus)
YOU MAY ALSO LIKE
A device designed to remove the magnetic properties of an object or material.
A disorder characterized by the presence of one or more nonbizarre delusions that persist for at least 1 month; the delusion(s) are…
False personal beliefs held contrary to reality, despite contradictory evidence and common sense.
The muscle that creates the rounded contour of the shoulder which originates from the lateral third of the clavicle, the superior surface…
Deltex Homolog 1, encoded by the human DTX1 gene, is a transcription corepressor. Notch1 activates CSL by displacing corerepssors and recruiting…
A genus in the family retroviridae consisting of exogenous horizontally transmitted viruses found in mammals; associated with B or T cell leukemia/lymphoma…
